methyl 3,3-dimethylpentanoyl chloride | 934270-79-8

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 酰卤
• 英文名称: methyl 3,3-dimethylpentanoyl chloride
• 英文别名: 3,3-Dimethylhexanoyl chloride；3,3-dimethylhexanoyl chloride
• CAS: 934270-79-8
• 化学式: C₈H₁₅ClO
• 分子量: 162.66
• InChiKey: BORRIXPXJGCERH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  methyl 3,3-dimethylpentanoyl chloride 在 lithium aluminium tetrahydride 、 三乙胺 、 zinc(II) iodide 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 反应 20.5h， 生成 (2S)-2-[[(1R)-2-hydroxy-1-phenyl-ethyl]amino]-3,3-dimethyl-pentanenitrile
  参考文献：
  名称：

  [EN] ARYLAMIDES AND METHODS OF USE THEREOF
  [FR] ARYLAMIDES ET LEURS PROCÉDÉS D'UTILISATION

  摘要：

  本公开涉及杂环化合物，其药用盐以及药物制剂。本文还描述了这些化合物的组成以及在治疗由CFTR活性不足介导的疾病和病况的方法中的使用，特别是囊性纤维化。

  公开号：

  WO2021113809A1

文献信息

• CELLULOSE DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF, CELLULOSE RESIN COMPOSITION, MOLDED ARTICLE AND METHOD FOR PRODUCTION THEREOF, AND HOUSING FOR ELECTROCHEMICAL DEVICE
  申请人：FUJIFILM Corporation

  公开号：EP2295470A1

  公开（公告）日：2011-03-16

  A cellulose derivative having good thermal plasticity, strength, heat resistance and mold working suitability is provided. The cellulose derivative is a cellulose derivative obtained from cellulose by substitution of hydrocarbyl groups ranging in carbon number from 1 to 7 and aliphatic acyl groups ranging in carbon number from 4 to 11 for at least part of the hydrogen atoms of hydroxyl groups contained in the cellulose.

  提供了一种具有良好热可塑性、强度、耐热性和模具加工适应性的纤维素衍生物。 这种纤维素衍生物是从纤维素中通过用碳原子数为 1 至 7 的烃基和碳原子数为 4 至 11 的脂肪酰基取代纤维素中所含羟基的至少部分氢原子而得到的纤维素衍生物。
• Discovery of Selective and Potent Inhibitors of Gram-Positive Bacterial Thymidylate Kinase (TMK)
  作者：Gabriel Martínez-Botella、John N. Breen、James E. S. Duffy、Jacques Dumas、Bolin Geng、Ian K. Gowers、Oluyinka M. Green、Satenig Guler、Martin F. Hentemann、Felix A. Hernandez-Juan、Diane Joseph-McCarthy、Sameer Kawatkar、Nicholas A. Larsen、Ovadia Lazari、James T. Loch、Jacqueline A. Macritchie、Andrew R. McKenzie、Joseph V. Newman、Nelson B. Olivier、Linda G. Otterson、Andrew P. Owens、Jon Read、David W. Sheppard、Thomas A. Keating

  DOI：10.1021/jm3011806

  日期：2012.11.26

  Thymidylate kinase (TMK) is an essential enzyme in bacterial DNA synthesis. The deoxythymidine monophosphate (dTMP) substrate binding pocket was targeted in rational-design, structure-supported effort, yielding a unique series of antibacterial agents showing a novel, induced-fit binding mode. Lead optimization, aided by X-ray crystallography, led to picomolar inhibitors of both Streptococcus pneumoniae and Staphylococcus aureus TMK. MICs < 1 mu g/mL were achieved against methicillin-resistant S. aureus (MRSA), S. pneumoniae, and vancomycin-resistant. Enterococcus (VRE). Log D adjustments yielded single diastereomers 14 (TK-666) and 46, showing a broad antibacterial spectrum against Gram-positive bacteria and excellent selectivity against the human thymidylate kinase ortholog.
• CELLULOSE DERIVATIVE AND METHOD FOR PRODUCING THE SAME, CELLULOSE RESIN COMPOSITION, MOLDED MATTER AND METHOD FOR MAKING THE SAME, AND ELECTRICAL AND ELECTRONIC EQUIPMENT HOUSING
  申请人：Yoshitani Toshihide

  公开号：US20110098463A1

  公开（公告）日：2011-04-28

  A cellulose derivative obtained from cellulose by substitution of hydrocarbyl groups ranging in carbon number from 1 to 7 and aliphatic acyl groups ranging in carbon number from 4 to 11 for at least part of the hydrogen atoms of hydroxyl groups contained in the cellulose. The cellulose derivative can exhibit good thermal plasticity, strength, heat resistance and mold working suitability.
• [EN] USE OF SUBSTITUTED 2,5-DIAMIDOINDOLES FOR THE TREATMENT OF UROLOGICAL DISEASES<br/>[FR] UTILISATION DE 2,5-DIAMIDOINDOLES SUBSTITUES POUR LE TRAITEMENT DE MALADIES UROLOGIQUES
  申请人：BAYER HEALTHCARE AG

  公开号：WO2004056768A2

  公开（公告）日：2004-07-08

  The present invention relates to the use of 2,5-diamidoindole derivatives for the preparation of medicaments for treating urological disorders in humans and/or animals, by virtue of their endothelin-converting enzyme (ECE) inhibitory activity.
• [EN] ARYLAMIDES AND METHODS OF USE THEREOF<br/>[FR] ARYLAMIDES ET LEURS PROCÉDÉS D'UTILISATION
  申请人：GENZYME CORP

  公开号：WO2021113809A1

  公开（公告）日：2021-06-10

  The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.

  本公开涉及杂环化合物，其药用盐以及药物制剂。本文还描述了这些化合物的组成以及在治疗由CFTR活性不足介导的疾病和病况的方法中的使用，特别是囊性纤维化。